Verona Pharma Plc ADR’s recently made public that its Officer MARK HAHN acquired Company’s shares for reported $3.47 million on Oct 18 ’24. In the deal valued at $34.66 per share,100,000 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, DAVID ZACCARDELLI bought 100,000 shares, generating $3,466,000 in total proceeds.
Before that, ZACCARDELLI DAVID sold 600,000 shares. Verona Pharma Plc ADR shares valued at $2,254,320 were divested by the President and CEO at a price of $3.76 per share. As a result of the transaction, ZACCARDELLI DAVID now holds 15,250,704 shares, worth roughly $533.32 million.
Wells Fargo initiated its Verona Pharma Plc ADR [VRNA] rating to an Overweight in a research note published on October 03, 2024; the price target was $50. Piper Sandler started covering the stock on August 26, 2022. It rated VRNA as “an Overweight”.
Price Performance Review of VRNA
On Monday, Verona Pharma Plc ADR [NASDAQ:VRNA] saw its stock jump 0.98% to $34.97. Over the last five days, the stock has gained 2.07%. Verona Pharma Plc ADR shares have risen nearly 75.91% since the year began. Nevertheless, the stocks have risen 162.73% over the past one year. While a 52-week high of $35.28 was reached on 10/18/24, a 52-week low of $11.39 was recorded on 05/30/24. SMA at 50 days reached $29.31, while 200 days put it at $19.89.
Levels Of Support And Resistance For VRNA Stock
The 24-hour chart illustrates a support level at 34.40, which if violated will result in even more drops to 33.82. On the upside, there is a resistance level at 35.40. A further resistance level may holdings at 35.82. The Relative Strength Index (RSI) on the 14-day chart is 75.09, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 2.06, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 4.60%. Stochastics %K at 94.92% indicates the stock is a selling.
How much short interest is there in Verona Pharma Plc ADR?
A steep rise in short interest was recorded in Verona Pharma Plc ADR stocks on 2024-09-30, dropping by -1.0 million shares to a total of 8.01 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-30 was 9.01 million shares. There was a decline of -12.45%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 13, 2021 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $25 price target.
